| Code | CSB-MP009438MO1 |
| Abbreviation | Recombinant Mouse Gipr protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Gastric inhibitory polypeptide receptor plays a central role in glucose homeostasis and energy metabolism, making its extracellular domain a key target for therapeutic antibody development in obesity and metabolic disease research. This partial construct spanning residues 19–134 captures the ligand-binding region and demonstrates quantifiable binding activity in functional ELISA, where immobilized protein at 2 μg/mL binds an anti-Gipr recombinant antibody with an EC50 of 8.622–11.36 ng/mL—a result that supports its use in competitive inhibition assays, blocking antibody screening, and therapeutic antibody epitope mapping. Mammalian expression preserves native glycosylation and disulfide bond formation critical for conformational integrity in receptor-ligand interaction studies, including surface plasmon resonance and biolayer interferometry experiments. The protein meets quality thresholds commonly required for drug discovery applications, with greater than 95% purity by SDS-PAGE and endotoxin levels below 1.0 EU/μg, providing a suitable basis for small-molecule or biologic inhibitor screening platforms.
There are currently no reviews for this product.